摘要
目的系统评价甲壳质酶蛋白(YKL-40)在阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者中的表达水平及与疾病的相关性。方法计算机检索PubMed、EMbase、MEDLINE、CNKI、WanFangData和VIP数据库,同时辅以Google学术检索等,搜集血浆YKL.40水平与OSAHS相关性的病例-对照研究,检索时限均为建库至2017年4月。由2位研究者独立筛选文献、提取资料并评价纳入研究的偏倚风险后,采用RevMan5.3软件进行Meta分析。结果最终纳入5个研究,OSAHS患者和对照人群共755例。Meta分析结果显示:与对照组相比,OSAHS患者的血浆YKL-40水平更高[SMD=1.20,95%CI(0.33,2.06),P=0.007];亚组分析结果显示,亚洲人群OSAHS患者的血浆YKL-40水平较对照组更高[SMD=1.79,95%CI(0.83,2.75),P=0.0002]。轻.中症与重症组OSAHS患者血浆YKL-40水平比较结果显示,轻症OSAHS患者的血浆YKL-40水平更低[SMD=-0.83,95%CI(-1.46,-0.19),P=0.01]。结论现有证据表明,YKL-40水平与OSAHS的发病可能有关。受纳入研究数量和质量限制,上述结论尚需开展更多高质量研究予以验证。
Objective To systematically review the association between the level of plasma YKL-40 and obstructive sleep apnea hypopnea syndrome (OSAHS). Methods We searched PubMed, EMbase, MEDLINE, CNKI, WanFang Data, VIP database and supplemented by Google academic retrieval to collect case-control studies about the association between the level of plasma YKL-40 and O SAHS from inception to April 2017. Two reviewers independently screened literature, extracted data and evaluated the risk of bias of included studies. And then, meta-analysis was performed by RevMan 5.3 software. Results A total of 5 case-control studies were included, involving 755 OSAHS patients and control population. The results of meta-analysis showed that the level of plasma YKL-40 in OSAHS patients was higher than that in control group (SMD=1.20, 95%CI 0.33 to 2.06, P=0.007). The subgroup analysis showed that the level of plasma YKL-40 in OSAHS patients from Asia was significantly higher than that in control group (SMD=1.79, 95%CI 0.83 to 2.75, P=0.000 2). The comparison between different severity of OSAHS showed that the wild- medium group had lower plasma level of YKL-40 than the severe group (SMD=-0.83, 95%CI -1.46 to -0.19, P=0.01). Conclusion YKL-40 may play an important role in the pathogenesis of OSAHS. Due to limited quantity and quality of the included studies, more high quality studies are needed to verify above conclusions.
作者
白敏
杨雪
童翔
刘思彤
王东光
范红
BAI Min;YANG Xue;TONG Xiang;LIU Sitong;WANG Dongguang;FAN Hong(Department of Respiratory &Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China)
出处
《中国循证医学杂志》
CSCD
北大核心
2018年第4期354-358,共5页
Chinese Journal of Evidence-based Medicine
基金
四川省人力资源与社会保障厅基金项目(编号:2015-100-13)
国家重点研发计划项目(编号:2017YFC1309703)